Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Apply
Risankizumab
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step